Molecular evidence of drug resistance in asymptomatic malaria Infections, Myanmar, 2015

Myat Htut Nyunt; Thinzar Shein; Ni Ni Zaw; Soe Soe Han; Fauzi Muh; Seong-Kyun Lee; Jin-Hee Han; Kyaw Zin Thant; Eun-Taek Han; Myat Phone Kyawl

doi:10.3201/eid2303.161363

Molecular evidence of drug resistance in asymptomatic malaria Infections, Myanmar, 2015

Myat Htut Nyunt
, Thinzar Shein
, Ni Ni Zaw
, Soe Soe Han
, Fauzi Muh
, Seong-Kyun Lee
, Jin-Hee Han
, Kyaw Zin Thant
, Eun-Taek Han^*
, Myat Phone Kyawl

^*Corresponding author for this work

School of Medicine

Research output: Contribution to journal › Article › peer-review

Abstract

Artennisinin resistance containment in Myanmar was initiated in 2011 after artemisinin-resistant Plasmodium falciparum malaria was reported. Molecular evidence suggests that asymptomatic malaria infections harboring drug resistance genes are present among residents of the Myanmar artemisinin resistance containment zone. This evidence supports efforts to eliminate these hidden infections.

Original language	English
Pages (from-to)	517-520
Number of pages	4
Journal	Emerging Infectious Diseases
Volume	23
Issue number	3
Early online date	17 Feb 2017
DOIs	https://doi.org/10.3201/eid2303.161363
Publication status	Published - Mar 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Plasmodium-vivax
PVMDR1
Chloroquine
Falciparum
Thailand

Access to Document

10.3201/eid2303.161363Licence: CC BY

Nyunt-2017-Molecular-evidence-517-CC
© 2017, the Author(s). This work has been made available online in accordance with the publisher's policies. This is the final published version of the work, which was originally published at http://dx.doi.org/10.3201/eid2303.161363
Final published version, 798 KBLicence: CC BY

Handle.net

Persistent link

Cite this

@article{f54129ae761d40b695e0e25dc6cbadf8,

title = "Molecular evidence of drug resistance in asymptomatic malaria Infections, Myanmar, 2015",

abstract = "Artennisinin resistance containment in Myanmar was initiated in 2011 after artemisinin-resistant Plasmodium falciparum malaria was reported. Molecular evidence suggests that asymptomatic malaria infections harboring drug resistance genes are present among residents of the Myanmar artemisinin resistance containment zone. This evidence supports efforts to eliminate these hidden infections.",

keywords = "Plasmodium-vivax, PVMDR1, Chloroquine, Falciparum, Thailand",

author = "Nyunt, \{Myat Htut\} and Thinzar Shein and Zaw, \{Ni Ni\} and Han, \{Soe Soe\} and Fauzi Muh and Seong-Kyun Lee and Jin-Hee Han and Thant, \{Kyaw Zin\} and Eun-Taek Han and Kyawl, \{Myat Phone\}",

year = "2017",

month = mar,

doi = "10.3201/eid2303.161363",

language = "English",

volume = "23",

pages = "517--520",

journal = "Emerging Infectious Diseases",

issn = "1080-6040",

publisher = "Centers for Disease Control and Prevention (CDC)",

number = "3",

}

TY - JOUR

T1 - Molecular evidence of drug resistance in asymptomatic malaria Infections, Myanmar, 2015

AU - Nyunt, Myat Htut

AU - Shein, Thinzar

AU - Zaw, Ni Ni

AU - Han, Soe Soe

AU - Muh, Fauzi

AU - Lee, Seong-Kyun

AU - Han, Jin-Hee

AU - Thant, Kyaw Zin

AU - Han, Eun-Taek

AU - Kyawl, Myat Phone

PY - 2017/3

Y1 - 2017/3

N2 - Artennisinin resistance containment in Myanmar was initiated in 2011 after artemisinin-resistant Plasmodium falciparum malaria was reported. Molecular evidence suggests that asymptomatic malaria infections harboring drug resistance genes are present among residents of the Myanmar artemisinin resistance containment zone. This evidence supports efforts to eliminate these hidden infections.

AB - Artennisinin resistance containment in Myanmar was initiated in 2011 after artemisinin-resistant Plasmodium falciparum malaria was reported. Molecular evidence suggests that asymptomatic malaria infections harboring drug resistance genes are present among residents of the Myanmar artemisinin resistance containment zone. This evidence supports efforts to eliminate these hidden infections.

KW - Plasmodium-vivax

KW - PVMDR1

KW - Chloroquine

KW - Falciparum

KW - Thailand

U2 - 10.3201/eid2303.161363

DO - 10.3201/eid2303.161363

M3 - Article

SN - 1080-6040

VL - 23

SP - 517

EP - 520

JO - Emerging Infectious Diseases

JF - Emerging Infectious Diseases

IS - 3

ER -

Molecular evidence of drug resistance in asymptomatic malaria Infections, Myanmar, 2015

Abstract

UN SDGs

Keywords

Access to Document

Handle.net

Fingerprint

Cite this